TXLNB

gene
On this page

Also known as DKFZp451A175MDP77dJ522B19.2

Summary

TXLNB (taxilin beta, HGNC:21617) is a protein-coding gene on chromosome 6q24.1, encoding Beta-taxilin (Q8N3L3). Promotes motor nerve regeneration.

Predicted to enable syntaxin binding activity. Located in cytoplasm.

Source: NCBI Gene 167838 — RefSeq curated summary.

At a glance

  • GWAS associations: 6
  • Clinical variants (ClinVar): 75 total
  • MANE Select transcript: NM_153235

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21617
Approved symbolTXLNB
Nametaxilin beta
Location6q24.1
Locus typegene with protein product
StatusApproved
AliasesDKFZp451A175, MDP77, dJ522B19.2
Ensembl geneENSG00000164440
Ensembl biotypeprotein_coding
OMIM611438
Entrez167838

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 3 protein_coding_CDS_not_defined, 2 protein_coding, 1 nonsense_mediated_decay

ENST00000358430, ENST00000367652, ENST00000715942, ENST00000715943, ENST00000715944, ENST00000715945

RefSeq mRNA: 1 — MANE Select: NM_153235 NM_153235

CCDS: CCDS34545

Canonical transcript exons

ENST00000358430 — 10 exons

ExonStartEnd
ENSE00001421552139240061139243314
ENSE00001422744139291921139291998
ENSE00001431226139288476139288913
ENSE00004028407139276830139276921
ENSE00004028408139247817139247909
ENSE00004028409139262579139262773
ENSE00004028413139260318139260437
ENSE00004028415139244595139244690
ENSE00004028417139255564139255638
ENSE00004028420139270456139270626

Expression profiles

Bgee: expression breadth ubiquitous, 187 present calls, max score 98.94.

FANTOM5 (CAGE): breadth broad, TPM avg 4.4094 / max 620.9152, expressed in 596 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
759483.7844518
759470.293364
759490.209162
759500.060933
759460.055020
759430.00682

Top tissues by expression

237 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
vastus lateralisUBERON:000137998.94gold quality
quadriceps femorisUBERON:000137798.80gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451198.80gold quality
skeletal muscle tissueUBERON:000113498.19gold quality
hindlimb stylopod muscleUBERON:000425298.15gold quality
biceps brachiiUBERON:000150798.14gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450297.97gold quality
deltoidUBERON:000147696.53gold quality
gastrocnemiusUBERON:000138896.33gold quality
muscle of legUBERON:000138395.93gold quality
muscle tissueUBERON:000238595.50gold quality
left ventricle myocardiumUBERON:000656694.88gold quality
cardiac muscle of right atriumUBERON:000337994.40gold quality
body of tongueUBERON:001187694.34gold quality
tibialis anteriorUBERON:000138593.60gold quality
myocardiumUBERON:000234993.53gold quality
heart right ventricleUBERON:000208091.78gold quality
heart left ventricleUBERON:000208491.13gold quality
cardiac ventricleUBERON:000208291.07gold quality
cardiac atriumUBERON:000208190.10gold quality
apex of heartUBERON:000209890.06gold quality
right atrium auricular regionUBERON:000663189.87gold quality
heartUBERON:000094887.20gold quality
tongueUBERON:000172384.78gold quality
bronchial epithelial cellCL:000232878.77gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099178.66silver quality
mucosa of paranasal sinusUBERON:000503077.41gold quality
bronchusUBERON:000218577.05gold quality
calcaneal tendonUBERON:000370174.85gold quality
left ovaryUBERON:000211974.80gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.29

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

141 targeting TXLNB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3924100.0072.092394
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-656-3P100.0072.152788
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-432-3P100.0067.86705
HSA-MIR-511-3P99.9968.851467
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-1236-3P99.9468.041695
HSA-MIR-539-5P99.9370.302855
HSA-MIR-314399.9371.963104
HSA-MIR-6508-5P99.9270.672465
HSA-MIR-7-1-3P99.9171.534384
HSA-MIR-7-2-3P99.9171.404394
HSA-MIR-454-3P99.9174.011925

Literature-anchored findings (GeneRIF, showing 1)

  • identification of isoforms of taxilin; interaction with syntaxin; tissue distribution [beta-taxilin, gamma-taxilin]. (PMID:15184072)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriotxlnbaENSDARG00000020594
danio_reriotxlnbbENSDARG00000076241
mus_musculusTxlnbENSMUSG00000039891
rattus_norvegicusTxlnbENSRNOG00000060021
drosophila_melanogasterCG5886FBGN0039379
caenorhabditis_elegansT22C1.6WBGENE00011917

Paralogs (2): TXLNA (ENSG00000084652), TXLNG (ENSG00000086712)

Protein

Protein identifiers

Beta-taxilinQ8N3L3 (reviewed: Q8N3L3)

Alternative names: Muscle-derived protein 77

All UniProt accessions (2): Q8N3L3, H7BY59

UniProt curated annotations — full annotation on UniProt →

Function. Promotes motor nerve regeneration. May be involved in intracellular vesicle traffic.

Subunit / interactions. Binds to the C-terminal coiled coil region of syntaxin family members STX1A, STX3A and STX4A. Has a preference for STX1A.

Tissue specificity. Expressed in skeletal muscle.

Similarity. Belongs to the taxilin family.

RefSeq proteins (1): NP_694967* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026183Taxilin_famFamily

Pfam: PF09728

UniProt features (21 total): compositionally biased region 6, region of interest 4, sequence variant 4, modified residue 2, sequence conflict 2, coiled-coil region 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N3L3-F168.830.37

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 474, 483

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 101 (showing top): GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP, TATTATA_MIR374, GOMF_SYNTAXIN_BINDING, GOMF_SNARE_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, F10_TARGET_GENES, TERF1_TARGET_GENES, ZIM3_TARGET_GENES, ZNF169_TARGET_GENES, ZNF2_TARGET_GENES, ZNF843_TARGET_GENES, MIR153_5P, MIR7_1_3P

GO Biological Process (0):

GO Molecular Function (2): syntaxin binding (GO:0019905), protein binding (GO:0005515)

GO Cellular Component (1): cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
SNARE binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

708 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TXLNBSTX8Q9UNK0763
TXLNBSTX7O15400719
TXLNBSTX3Q13277718
TXLNBSTX4Q12846707
TXLNBSTX1AQ16623647
TXLNBTMEM236Q5W0B7627
TXLNBCCDC158Q5M9N0516
TXLNBCIMAP3Q8TCI5473
TXLNBRNF122Q9H9V4470
TXLNBSYBUQ9NX95462
TXLNBIGSF5Q9NSI5458
TXLNBZFYVE26Q68DK2447
TXLNBCDHR3Q6ZTQ4442
TXLNBPRPF6O94906438
TXLNBSHISA6Q6ZSJ9434

IntAct

292 interactions, top by confidence:

ABTypeScore
TXLNBTXLNApsi-mi:“MI:0915”(physical association)0.880
TXLNATXLNBpsi-mi:“MI:0915”(physical association)0.880
TXLNBKRT38psi-mi:“MI:0915”(physical association)0.830
LURAP1TXLNBpsi-mi:“MI:0915”(physical association)0.830
TXLNBLURAP1psi-mi:“MI:0915”(physical association)0.830
KRT38TXLNBpsi-mi:“MI:0915”(physical association)0.830
CEP70TXLNBpsi-mi:“MI:0915”(physical association)0.780
TXLNBDEUP1psi-mi:“MI:0915”(physical association)0.720
DEUP1TXLNBpsi-mi:“MI:0915”(physical association)0.720
TXLNBCCDC196psi-mi:“MI:0915”(physical association)0.720
VIMTXLNBpsi-mi:“MI:0915”(physical association)0.720
KRT15TXLNBpsi-mi:“MI:0915”(physical association)0.720
TXLNBNMIpsi-mi:“MI:0915”(physical association)0.720
TXLNBUSHBP1psi-mi:“MI:0915”(physical association)0.720
NMITXLNBpsi-mi:“MI:0915”(physical association)0.720
DYDC1TXLNBpsi-mi:“MI:0915”(physical association)0.720

BioGRID (132): TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid), TXLNB (Two-hybrid)

ESM2 similar proteins: A1L260, A2AMM0, A2VDA9, A5PJI6, B1PRL5, O35867, O54724, O75410, O94876, O95810, P85125, Q13625, Q2T9X8, Q3U1C4, Q53HC0, Q5BKX8, Q5RBY6, Q5RDH2, Q5RKG1, Q5T1M5, Q63918, Q66H98, Q69ZZ6, Q6AYB8, Q6INU2, Q6IRU7, Q6NRH3, Q6NTW1, Q6NZI2, Q6P9Q6, Q6ZPJ0, Q7TNY7, Q7ZWE6, Q80U16, Q80Z25, Q86YF9, Q8BHS8, Q8BMD2, Q8C804, Q8CG79

Diamond homologs: P40222, Q6GVM5, Q6PAM1, Q8BHN1, Q8N3L3, Q8VBT1, Q9BZA5, Q9I969, Q9NUQ3

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 71 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Formation of the cornified envelope1124.2×9e-11
Loss of Nlp from mitotic centrosomes519.8×2e-04
Loss of proteins required for interphase microtubule organization from the centrosome519.8×2e-04
AURKA Activation by TPX2519.0×2e-04
Recruitment of mitotic centrosome proteins and complexes517.0×3e-04
Regulation of PLK1 Activity at G2/M Transition515.9×4e-04
Keratinization1115.3×7e-09
Recruitment of NuMA to mitotic centrosomes514.6×5e-04

GO biological processes:

GO termPartnersFoldFDR
morphogenesis of an epithelium1059.3×1e-13
intermediate filament organization1354.0×3e-17
epithelial cell differentiation927.2×5e-09

Disease & clinical

Clinical variants and AI predictions

ClinVar

75 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance65
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1653 predictions. Top by Δscore:

VariantEffectΔscore
6:139244588:T:TAdonor_gain1.0000
6:139244590:CTCA:Cdonor_loss1.0000
6:139244591:TCA:Tdonor_loss1.0000
6:139244592:CAC:Cdonor_loss1.0000
6:139244594:CCT:Cdonor_gain1.0000
6:139244686:GTTGT:Gacceptor_gain1.0000
6:139244687:TTGT:Tacceptor_gain1.0000
6:139244688:TGT:Tacceptor_gain1.0000
6:139244688:TGTC:Tacceptor_loss1.0000
6:139244690:TC:Tacceptor_loss1.0000
6:139244691:C:CCacceptor_gain1.0000
6:139244691:CTACA:Cacceptor_loss1.0000
6:139244692:T:Gacceptor_loss1.0000
6:139247809:ATACT:Adonor_loss1.0000
6:139247811:ACT:Adonor_loss1.0000
6:139247812:CTC:Cdonor_loss1.0000
6:139247812:CTCA:Cdonor_gain1.0000
6:139247813:TCAC:Tdonor_loss1.0000
6:139247814:CACTT:Cdonor_loss1.0000
6:139247815:A:ACdonor_gain1.0000
6:139247815:ACTTT:Adonor_loss1.0000
6:139247816:C:CGdonor_gain1.0000
6:139247816:CT:Cdonor_gain1.0000
6:139247816:CTT:Cdonor_gain1.0000
6:139247816:CTTT:Cdonor_gain1.0000
6:139247816:CTTTG:Cdonor_gain1.0000
6:139247905:GTGAG:Gacceptor_gain1.0000
6:139247906:TGAG:Tacceptor_gain1.0000
6:139247907:GAG:Gacceptor_gain1.0000
6:139247908:AG:Aacceptor_gain1.0000

AlphaMissense

4520 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:139262616:A:GL282P1.000
6:139262628:A:GL278P1.000
6:139260386:C:GA312P0.999
6:139260394:A:GL309P0.999
6:139260400:T:GQ307P0.999
6:139260406:A:GL305P0.999
6:139260433:A:GL296P0.999
6:139262626:C:GA279P0.999
6:139262649:A:GL271P0.999
6:139262661:C:GR267P0.999
6:139262700:A:GL254P0.999
6:139262712:A:GF250S0.999
6:139270481:A:GL221P0.999
6:139270487:C:GR219P0.999
6:139270511:C:GR211P0.999
6:139243247:C:GR445P0.998
6:139247866:A:GL374P0.998
6:139247908:A:GL360P0.998
6:139260371:C:GA317P0.998
6:139260379:A:GL314P0.998
6:139262586:C:AR292I0.998
6:139262598:T:GQ288P0.998
6:139262616:A:TL282Q0.998
6:139262628:A:TL278H0.998
6:139262636:G:CN275K0.998
6:139262636:G:TN275K0.998
6:139262637:T:AN275I0.998
6:139262638:T:CN275D0.998
6:139262711:G:CF250L0.998
6:139262711:G:TF250L0.998

dbSNP variants (sampled 300 via entrez): RS1000014570 (6:139182436 G>GTT), RS1000015718 (6:139198003 C>T), RS1000040674 (6:139216630 A>G), RS1000040893 (6:139170304 C>G,T), RS1000041574 (6:139287812 C>T), RS1000045130 (6:139260907 C>T), RS1000050518 (6:139266519 T>C), RS1000054403 (6:139177312 G>A,C,T), RS1000068165 (6:139325186 G>A,T), RS1000094964 (6:139288177 A>G), RS1000107501 (6:139217057 A>G), RS1000112450 (6:139168793 T>C), RS1000139642 (6:139261280 C>A), RS1000179439 (6:139268586 T>C), RS1000190101 (6:139164320 G>A)

Disease associations

OMIM: gene MIM:611438 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

6 associations (top):

StudyTraitp-value
GCST005240_1Caudate volume in trauma-exposed individuals2.000000e-07
GCST005956_33Waist-to-hip ratio adjusted for BMI6.000000e-09
GCST005962_46Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)6.000000e-08
GCST005987_41Albumin-globulin ratio8.000000e-11
GCST005990_57Non-albumin protein levels2.000000e-10
GCST006979_399Heel bone mineral density2.000000e-12

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0004830caudate nucleus volume
EFO:0008483response to trauma exposure
EFO:0007788BMI-adjusted waist-hip ratio
EFO:0008007age at assessment
EFO:0008343sex interaction measurement
EFO:0005128albumin:globulin ratio measurement
EFO:0009270heel bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs9495425TXLNB0.000

CTD chemical–gene interactions

16 total (human), top 16 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression3
triphenyl phosphateaffects expression1
arseniteaffects binding, decreases reaction1
sodium arseniteincreases expression1
CGP 52608affects binding, increases reaction1
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidineincreases expression, increases response to substance1
incobotulinumtoxinAdecreases expression1
Sunitinibdecreases expression1
Arsenicaffects methylation1
Doxorubicindecreases expression1
N-Nitrosopyrrolidinedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tretinoinincreases expression1
Triclosandecreases expression1
Okadaic Acidincreases expression1
Lactic Acidincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.